Pradaxa Induced Internal Bleeding
Pradaxa, an anti-coagulant blood thinning medication, is manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is commonly prescribed to reduce stroke risk in patients suffering from atrial fibrillation.
The U.S. Food and Drug Administration (FDA) approved the drug for consumer use in 2010. Since its approval, patients have filed lawsuits against Boehringer Ingelheim Pharmaceuticals alleging the company did not provide adequate warnings about the use of Pradaxa. It is alleged the company failed to provide notice to physicians related to certain necessary procedures and characteristics of the drug that can also complicate ordinary medical protocol when providing services to a patient that has severe bleeding.
The most frequent complications cited by such consumers include:
- Gastrointestinal Bleeds
- Cerebral Hemorrhaging
- Severe Internal Bleeding
Complications From Using Pradaxa? Contact a Kansas City Lawyer
If you or a loved one has suffered severe internal bleeding from being administered or prescribed Pradaxa, you should protect your legal rights. Contact an attorney with the skills and resources to pursue your claim and seek compensation for your injuries.